CD19/CD20 dual-targeted chimeric antigen receptor-engineered natural killer cells exhibit improved cytotoxicity against acute lymphoblastic leukemia

被引：0
作者：
Na Yang
Caili Zhang
Yingchun Zhang
Yuting Fan
Jing Zhang
Xiaojin Lin
Ting Guo
Yangzuo Gu
Jieheng Wu
Jianmei Gao
Xing Zhao
Zhixu He
机构：
[1] Guizhou Medical University (GMU),Tissue Engineering and Stem Cell Experiment Center
[2] Guizhou Medical University,Department of Immunology, College of Basic Medical Sciences
[3] Guizhou Medical University,Department of Biology, School of Basic Medical Sciences
[4] the Affiliated Hospital of Guizhou Medical University,Department of Gynecology
[5] Sichuan University,State Key Laboratory of Biotherapy and Cancer Center
[6] Zunyi Medical University,School of Pharmacy
[7] Chinese Academy of Medical Sciences),Key Laboratory of Adult Stem Cell Translational Research
[8] the Affiliated Hospital of Zunyi Medical University,Department of Pediatrics
来源：
Journal of Translational Medicine | / 22卷
关键词：
Chimeric antigen receptor; Natural killer cells; Dual targets; mRNA; Acute lymphoblastic leukemia;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 45 条
  • [21] Could cytokine release syndrome induce acute myelofibrosis in CD19 chimeric antigen receptor T cells therapy?
    Lai, Xun
    Sun, Yun Yan
    Chang, Lung Ji
    Ma, Yu Ru
    Gu, Xue Zhong
    Yao, Xiang Mei
    Nie, Bo
    Wen, Yan
    Zhang, Xue Mei
    Jiang, Ya Xian
    Yang, Hui
    Yu, Li Qun
    Fang, Ming Jing
    Wang, Ling
    Bo, Xue Yuan
    BIOENGINEERED, 2020, 11 (01) : 824 - 828
  • [22] Irradiated chimeric antigen receptor engineered NK-92MI cells show effective cytotoxicity against CD19+ malignancy in a mouse model
    Liu, Qian
    Xu, Yingxi
    Mou, Junli
    Tang, Kejing
    Fu, Xuehang
    Li, Yihui
    Xing, Yanyan
    Rao, Qing
    Xing, Haiyan
    Tian, Zheng
    Wang, Min
    Wang, Jianxiang
    CYTOTHERAPY, 2020, 22 (10) : 552 - 562
  • [23] Targeting B7-H3 Immune Checkpoint With Chimeric Antigen Receptor-Engineered Natural Killer Cells Exhibits Potent Cytotoxicity Against Non-Small Cell Lung Cancer
    Yang, Shuo
    Cao, Bihui
    Zhou, Guangyu
    Zhu, Lipeng
    Wang, Lu
    Zhang, Li
    Kwok, Hang Fai
    Zhang, Zhenfeng
    Zhao, Qi
    FRONTIERS IN PHARMACOLOGY, 2020, 11
  • [24] CD19-redirected chimeric antigen receptor-modified T cells: a promising immunotherapy for children and adults with B-cell acute lymphoblastic leukemia (ALL)
    Tasian, Sarah K.
    Gardner, Rebecca A.
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2015, 6 (05) : 228 - 241
  • [25] T cells raised against allogeneic HLA-A2/CD20 kill primary follicular lymphoma and acute lymphoblastic leukemia cells
    Abrahamsen, Ingerid Weum
    Kjellevoll, Synneva
    Greve-Isdahl, Margrethe
    Mensali, Nadia
    Walchli, Sebastien
    Kumari, Shraddha
    Loland, Beate Fossum
    Egeland, Torstein
    Kolstad, Arne
    Olweus, Johanna
    INTERNATIONAL JOURNAL OF CANCER, 2012, 130 (08) : 1821 - 1832
  • [26] Apparent CD19 Expression by Natural Killer Cells: A Potential Confounder for Minimal Residual Disease Detection by Flow Cytometry in B Lymphoblastic Leukemia
    Soma, Lorinda
    Wu, David
    Chen, Xueyan
    Edlefsen, Kerstin
    Fromm, Jonathan R.
    Wood, Brent
    CYTOMETRY PART B-CLINICAL CYTOMETRY, 2015, 88 (02) : 145 - 147
  • [27] Purinergic targeting enhances immunotherapy of CD73+ solid tumors with piggyBac-engineered chimeric antigen receptor natural killer cells
    Wang, Jiao
    Lupo, Kyle B.
    Chambers, Andrea M.
    Matosevic, Sandro
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2018, 6
  • [28] Humanized CD30-Targeted Chimeric Antigen Receptor T Cells Exhibit Potent Preclinical Activity Against Hodgkin's Lymphoma Cells
    Guo, Jing
    He, Shuai
    Zhu, Yongjie
    Yu, Wei
    Yang, Dong
    Zhao, Xudong
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2022, 9
  • [29] Anti-TIM3 chimeric antigen receptor-natural killer cells from engineered induced pluripotent stem cells effectively target acute myeloid leukemia cells
    Klaihmon, Phatchanat
    Luanpitpong, Sudjit
    Kang, Xing
    Issaragrisil, Surapol
    CANCER CELL INTERNATIONAL, 2023, 23 (01)
  • [30] Anti-TIM3 chimeric antigen receptor-natural killer cells from engineered induced pluripotent stem cells effectively target acute myeloid leukemia cells
    Phatchanat Klaihmon
    Sudjit Luanpitpong
    Xing Kang
    Surapol Issaragrisil
    Cancer Cell International, 23
12345